NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Sees Healthy Buying Interest

The Indian stock market witnessed significant buying interest on Thursday, 21 May, with both the Sensex and the Nifty 50 benchmarks experiencing a notable surge. The morning deals saw the Sensex jump over 600 points, or more than 0.80%, to reach an intraday high of 75,946. The Nifty 50 also rose by 0.85% to the day's high of 23,860.

This broad-based buying interest was reflected in the mid and small-cap indices on the BSE, which rose by 1% each. As a result, the overall market capitalisation of BSE-listed firms reached ₹464 lakh crore by 9:25 am, up from ₹461 lakh crore in the previous session. This increase in market capitalisation translates to investors becoming richer by approximately ₹3 lakh crore within the first 10 minutes of the session.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors may see sustained gains in the Indian stock market.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.